These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7895897)
1. Effect of an anxiolytic on lipid profile in non-insulin-dependent diabetes mellitus. Okada S; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z J Int Med Res; 1994; 22(6):338-42. PubMed ID: 7895897 [TBL] [Abstract][Full Text] [Related]
2. How blood pressure in patients with non-insulin-dependent diabetes mellitus is influenced by stress. Okada S; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z J Int Med Res; 1995; 23(5):377-80. PubMed ID: 8529781 [TBL] [Abstract][Full Text] [Related]
3. Improvement of stress reduces glycosylated haemoglobin levels in patients with type 2 diabetes. Okada S; Ichiki K; Tanokuchi S; Ishii K; Hamada H; Ota Z J Int Med Res; 1995; 23(2):119-22. PubMed ID: 7601294 [TBL] [Abstract][Full Text] [Related]
4. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients? Alagözlü H; Gültekin F; Candan F Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258 [TBL] [Abstract][Full Text] [Related]
5. Factors related to stress in patients with non-insulin-dependent diabetes mellitus. Okada S; Hamada H; Ishii K; Ichiki K; Tanokuchi S; Ota Z J Int Med Res; 1995; 23(6):449-57. PubMed ID: 8746612 [TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group. Kazumi T; Yoshino G; Ishida Y; Iwatani I; Morita S; Tateiwa M; Kasuga M Diabetes Res Clin Pract; 1995 Jan; 27(1):61-8. PubMed ID: 7781495 [TBL] [Abstract][Full Text] [Related]
7. Sex differences in plasma cholesterol and apolipoprotein B levels in non-obese type 2 diabetic subjects. Ikeda T; Terasawa H; Ishimura M; Ochi H; Ohtani D; Fujiyama K; Hoshino T; Tanaka Y; Mashiba H Diabete Metab; 1992; 18(6):465-7. PubMed ID: 1297605 [No Abstract] [Full Text] [Related]
8. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects. Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581 [TBL] [Abstract][Full Text] [Related]
9. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects. O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725 [TBL] [Abstract][Full Text] [Related]
10. Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus. Gallou G; Ruelland A; Campion L; Maugendre D; Le Moullec N; Legras B; Allannic H; Cloarec L Diabete Metab; 1994; 20(3):258-64. PubMed ID: 8001713 [TBL] [Abstract][Full Text] [Related]
11. The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM. Chan JC; Yeung VT; Leung DH; Tomlinson B; Nicholls MG; Cockram CS Diabetes Care; 1994 Aug; 17(8):859-62. PubMed ID: 7956631 [TBL] [Abstract][Full Text] [Related]
12. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects. Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control. Tan CE; Chew LS; Chio LF; Tai ES; Lim HS; Lim SC; Jayakumar L; Eng HK; Packard CJ Diabetes Res Clin Pract; 2001 Feb; 51(2):107-14. PubMed ID: 11165690 [TBL] [Abstract][Full Text] [Related]
14. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus. Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040 [TBL] [Abstract][Full Text] [Related]
15. Benefits of micronised Fenofibrate in type 2 diabetes mellitus subjects with good glycemic control. Tan CE; Chew LS; Tai ES; Chio LF; Lim HS; Loh LM; Shepherd J Atherosclerosis; 2001 Feb; 154(2):469-74. PubMed ID: 11166781 [TBL] [Abstract][Full Text] [Related]
16. Lipid and lipoprotein aberrations in Indian patients with non-insulin-dependent diabetes in the young. Jialal I; Deppe W; Joubert SM S Afr Med J; 1985 Jun; 67(25):1001-4. PubMed ID: 4012462 [TBL] [Abstract][Full Text] [Related]
17. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters. Pan J; Gao F; Bao Y; Zhang L; Tu Y; Jia W J Clin Lipidol; 2012; 6(4):382-7. PubMed ID: 22836076 [TBL] [Abstract][Full Text] [Related]
18. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes. Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732 [TBL] [Abstract][Full Text] [Related]
19. Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Zenobi PD; Holzmann P; Glatz Y; Riesen WF; Froesch ER Diabetologia; 1993 May; 36(5):465-9. PubMed ID: 8314453 [TBL] [Abstract][Full Text] [Related]